Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area

The emergence of drug-resistant tuberculosis (DR-TB) has become a significant health problem in India. Delays in diagnosis and treatment initiation are frequently observed among patients with DR-TB, resulting in an increased risk of disease complications and high mortality and pretreatment lost to f...

Full description

Bibliographic Details
Main Authors: A Bhagyalaxmi, Shikha Jain, Parimal Patel, Divya Barot
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Public Health
Subjects:
Online Access:http://www.ijph.in/article.asp?issn=0019-557X;year=2019;volume=63;issue=4;spage=377;epage=379;aulast=Bhagyalaxmi
_version_ 1818260905789489152
author A Bhagyalaxmi
Shikha Jain
Parimal Patel
Divya Barot
author_facet A Bhagyalaxmi
Shikha Jain
Parimal Patel
Divya Barot
author_sort A Bhagyalaxmi
collection DOAJ
description The emergence of drug-resistant tuberculosis (DR-TB) has become a significant health problem in India. Delays in diagnosis and treatment initiation are frequently observed among patients with DR-TB, resulting in an increased risk of disease complications and high mortality and pretreatment lost to follow-up rates. To understand the factors associated with delays between the diagnosis and treatment, the study was carried out in Ahmedabad Municipal Corporation Area. A total of 177 DR-TB patients diagnosed in the year 2014 who had a delay in the initiation of treatment, and 23 initial defaulters were studied using a structured questionnaire. Fifty-four DOTS providers were also interviewed. Of 177 patients, 62.15% initiated treatment between 7 and 15 days and nearly 12% of them started the treatment after a month. The median duration of delay was 12 days (range: 8–144 days and interquartile range: 9–20 days). The most common reason for the delay in the initiation and initial default was the social and personal factors (48.80%), and in 34 (20%) of the patients, the delay was attributed to the effect of the previous treatment.
first_indexed 2024-12-12T18:38:46Z
format Article
id doaj.art-460ec3bda2484d9781ecce257bcc9b1d
institution Directory Open Access Journal
issn 0019-557X
language English
last_indexed 2024-12-12T18:38:46Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Public Health
spelling doaj.art-460ec3bda2484d9781ecce257bcc9b1d2022-12-22T00:15:42ZengWolters Kluwer Medknow PublicationsIndian Journal of Public Health0019-557X2019-01-0163437737910.4103/ijph.IJPH_26_19Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation areaA BhagyalaxmiShikha JainParimal PatelDivya BarotThe emergence of drug-resistant tuberculosis (DR-TB) has become a significant health problem in India. Delays in diagnosis and treatment initiation are frequently observed among patients with DR-TB, resulting in an increased risk of disease complications and high mortality and pretreatment lost to follow-up rates. To understand the factors associated with delays between the diagnosis and treatment, the study was carried out in Ahmedabad Municipal Corporation Area. A total of 177 DR-TB patients diagnosed in the year 2014 who had a delay in the initiation of treatment, and 23 initial defaulters were studied using a structured questionnaire. Fifty-four DOTS providers were also interviewed. Of 177 patients, 62.15% initiated treatment between 7 and 15 days and nearly 12% of them started the treatment after a month. The median duration of delay was 12 days (range: 8–144 days and interquartile range: 9–20 days). The most common reason for the delay in the initiation and initial default was the social and personal factors (48.80%), and in 34 (20%) of the patients, the delay was attributed to the effect of the previous treatment.http://www.ijph.in/article.asp?issn=0019-557X;year=2019;volume=63;issue=4;spage=377;epage=379;aulast=Bhagyalaxmidefaulterdelaydrug resistanttreatmenttuberculosis
spellingShingle A Bhagyalaxmi
Shikha Jain
Parimal Patel
Divya Barot
Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
Indian Journal of Public Health
defaulter
delay
drug resistant
treatment
tuberculosis
title Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
title_full Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
title_fullStr Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
title_full_unstemmed Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
title_short Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area
title_sort reasons for the delay in the initiation of treatment and initial default among drug resistant tuberculosis patients in ahmedabad corporation area
topic defaulter
delay
drug resistant
treatment
tuberculosis
url http://www.ijph.in/article.asp?issn=0019-557X;year=2019;volume=63;issue=4;spage=377;epage=379;aulast=Bhagyalaxmi
work_keys_str_mv AT abhagyalaxmi reasonsforthedelayintheinitiationoftreatmentandinitialdefaultamongdrugresistanttuberculosispatientsinahmedabadcorporationarea
AT shikhajain reasonsforthedelayintheinitiationoftreatmentandinitialdefaultamongdrugresistanttuberculosispatientsinahmedabadcorporationarea
AT parimalpatel reasonsforthedelayintheinitiationoftreatmentandinitialdefaultamongdrugresistanttuberculosispatientsinahmedabadcorporationarea
AT divyabarot reasonsforthedelayintheinitiationoftreatmentandinitialdefaultamongdrugresistanttuberculosispatientsinahmedabadcorporationarea